Male breast cancer is a rare malignancy that accounts for less than 1% of all cancers in men
and less than 1% of all breast cancers. But the incidence is rising and in some patient …

Occurrence of male breast cancer, a rare disease, peaks at age 71 years. Familial cases
usually have BRCA2 rather than BRCA1 mutations. Occupational risks include high …

Male breast cancer (MaleBC) is a rare disease, accounting for< 1% of all male tumors.
During the last few years, there has been an increase in the incidence of this disease, along …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Background With increasing survival after cancer diagnoses, second primary cancers
(SPCs) are becoming more prevalent. We investigated the incidence and site of non-breast …

Recently, the number of studies on male breast cancer (MBC) has been increasing.
However, as MBC is a rare disease there are difficulties to undertake studies to identify …

Objectives The aim of this study was to estimate the extra risk of second primary cancer
among breast cancer patients. Methods and materials This is a systematic review. A …

Male breast cancer (MBC), one of the rare types of cancer among men where the global
incidence rate is 1.8% of all breast cancers cases with a yearly increase in a pace of 1.1 …

Background The male breast cancer (MBC) is a rare and represents less than 1% of all
malignancies in men and only 1% of all breast cancers incident. We illustrate the experience …

Breast cancer screening has been highly successful in women in reducing mortality through
early detection. In comparison, clinical detection of breast cancer remains the norm in men …